News & Events

Welcome to Dalton Pharma Services News and Events section. On this page you will find our current and past news releases, and a list of event happenings. If you can't find what you are looking for, contact us and we will be happy to provide you with assistance.

Click here to download our Corporate brochure.

Date		Articles
May 6, 2008		Dalton Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides
Mar 3, 2008		BIKAM and Dalton Medicinal Chemistry Sign Collaborative Research Agreement
Jan 23, 2008		Dalton Medicinal Chemistry Achieves Another Milestone with Boehringer Ingelheim (Canada) Ltd.
Jan 22, 2008		ImmunoVaccine Technologies Selects Dalton Pharma to Produce Promising Cancer Vaccine
Nov 13, 2007		BioRelix and Dalton jointly announced a research collaboration to discover new therapeutics
Oct 29, 2007		Dalton Medicinal Chemistry Partners Achieves Milestone with Boehringe Ingelheim Ltd.
June 14, 2007		Dalton and X-GEN Pharmaceuticals Inc. enter into a manufacturing services agreement
Mar 23, 2007		Dalton and Boehringer Ingelheim (Canada) Ltd. enter into a Medicinal Agreement
Mar 1, 2007		Dalton and Affectis Pharmaceuticals of Germany enter into a Contract Services Agreement
Jan 26, 2007		Health Canada approves Dalton for the delivery of commercial products
Aug 31, 2006		Dalton Pharma Services Launches Expanded Medicinal Chemistry Services
Apr 12, 2006		Dalton Announces Completion of GMP Oligonucleotide Manufacturing Facility
Mar 31, 2005		Dalton Announces Operating Name Change
Oct 25, 2004		Dalton Chemical Labs Inc. Completes it's $1.4 Million Expansion to it's Facilities
May 25, 2004		Stellar Inc. Moves it's Manufacturing to Dalton Inc.
Jan 10, 2004		Accelerating Drug Development
May 17, 2003		The Fine Art of Canadian Conversation
May 03, 2003		Race on to Realize Value of SARS Patent
May 01, 2003		CEO's Talk: From Job Security to Youth Mobility, Six Canadian CEO's Share Retention Strategies
Jun 30, 2002		Triad's Biotech Identity is Beginning to Emerge
Jun 20, 2002		Key Questions to Ask When Outsourcing Pre-clinical Development Services
Jun 11, 2002		Making Molecules Dalton Chemical has the Knack for Creating Elusive Molecules
Jun 04, 2002		Lorus Receives Fast Track Designation from FDA for Virulizin - Treatment of Pancreatic Cancer
Mar 12, 2001		Dalton Chemical Laboratories Inc. is to Manufacture Drug for Lorus Therapeutics
Apr 12, 2000		Dalton Chemical Laboratories... On the Move!
Jul 22, 1999		Custom Peptide Synthesis Launch